407 results on '"Bañez, Lionel"'
Search Results
52. Comparison of rituximab and conventional adjuvant therapy for pemphigus vulgaris: A retrospective analysis
53. PP22 How Do Health System Leaders Use Evidence To Inform Action?
54. Should a digital rectal examination be optional for early detection of prostate cancer in obese men?
55. Is Psa a poor predictor of prostate cancer in obese men? - results from a european biopsy cohort
56. Chapter 1 - IMPACT OF HOST FACTORS AND COMORBID CONDITIONS
57. Preoperative predictors of pathologic stage T2a and pathologic Gleason score ≤ 6 in men with clinical low-risk prostate cancer treated with radical prostatectomy: reference for active surveillance
58. The impact of obesity on the predictive accuracy of PSA in men undergoing prostate biopsy
59. 1638 UNILATERAL PROSTATE CANCER ANALYIS OF PREDICTORS IN SEARCH AND DUKE PROSTATE CENTER DATABASES
60. 1931 IS THE ASSOCIATION BETWEEN DUTASTERIDE USE AND PROSTATE CANCER RISK DIFFERENT IN MEN WITH A FAMILY HISTORY OF BREAST OR PROSTATE CANCERS?
61. 159 PROSTATE CANCER RISK IN MEN WITH PROSTATE AND BREAST CANCER FAMILY HISTORY: RESULTS FROM THE REDUCE STUDY
62. 341 ANDROGENETIC ALOPECIA AT VARIOUS AGES AND PROSTATE CANCER RISK IN AN EQUAL ACCESS MULTIETHNIC CASE CONTROL SERIES OF VETERANS
63. Prostate Cancer Risk in Men with Baseline History of Coronary Artery Disease: Results from the REDUCE Study
64. Preoperative Predictors of Pathologic Stage T2a in Low-Risk Prostate Cancer: Implications for Focal Therapy
65. Editorial Comment
66. 1613 GENETIC VARIATION IN OBESITY-RELATED GENES ADBR2, ADBR3, GHRL, HSD11B1, AND SHC1 AND RISK OF PROSTATE CANCER: A VA CASE-CONTROL STUDY
67. 1204 HEIGHT AND THE RISK FOR AGGRESSIVE PROSTATE CANCER AT THE TIME OF BIOPSY–RESULTS FROM THE DUKE PROSTATE CENTER DATABASE
68. 157 OBESITY INCREASES THE RISK FOR HIGH-GRADE PROSTATE CANCER: RESULTS FROM THE REDUCE STUDY
69. 2029 SHOULD A DIGITAL RECTAL EXAMINATION BE OPTIONAL FOR EARLY DETECTION OF PROSTATE CANCER IN OBESE MEN?
70. 997 RISK FOR RECURRENT PROSTATE CANCER INCREASES WITH CHOLESTEROL ON A CONTINUUM IN MEN WITH ABNORMAL CHOLESTEROL LEVELS - AN UPDATE FROM THE SEACH DATABASE
71. 2295 DOES HEMODILUTION OR DECREASED CIRCULATING ANDROGENS EXPLAIN LOWER PSA CONCENTRATIONS AMONG OBESE MEN? - RESULTS FROM THE REDUCE TRIAL
72. 1331 PREOPERATIVE ERECTILE DYSFUNCTION IS ASSOCIATED WITH LARGER TUMOR VOLUMES -AN ANALYSIS FROM THE DUKE PROSTATE CENTER DATABASE
73. 1205 DO METABOLIC COMORBIDITIES INFLUENCE THE ABILITY OF DUTASTERIDE TO LOWER PROSTATE CANCER RISK? RESULTS FROM THE REDUCE STUDY
74. 605 COMBINATION OF ADH GENE POLYMORPHISM AND ALCOHOL CONSUMPTION CONSTITUTES A NOVEL PROSTATE CANCER RISK FACTOR IN AFRICAN-AMERICAN MEN
75. Third Prize: The Role of Endoscopic Nephron-Sparing Surgery in the Management of Upper Tract Urothelial Carcinoma
76. MP14-13 WEIGHING IN ON ACTIVE SURVEILLANCE: IMPACT OF OBESITY ON PATIENT COUNSELING
77. Editorial Comment
78. Editorial Comment
79. Corrigendum to “Re: Effects of Simvastatin, Acetylsalicylic Acid, and Rosiglitazone on Proliferation of Normal and Cancerous Prostate Epithelial Cells at Therapeutic Concentrations” [Eur Urol 2010;57:542–3]
80. 1843 WEIGHT GAIN IS ASSOCIATED WITH LOWER PSA CONCENTRATIONS IN MEN WITHOUT PROSTATE CANCER FOLLOWED OVER TIME: EVIDENCE FOR OBESITY-RELATED PSA HEMODILUTION
81. 292 DOES INITIATING STATIN THERAPY AFTER RADICAL PROSTATECTOMY REDUCE THE RISK FOR BIOCHEMICAL RECURRENCE? – RESULTS FROM THE SEARCH DATABASE
82. Re: Effects of Simvastatin, Acetylsalicylic Acid, and Rosiglitazone on Proliferation of Normal and Cancerous Prostate Epithelial Cells at Therapeutic Concentrations
83. Association between Statins and Prostate Tumor Inflammatory Infiltrate in Men Undergoing Radical Prostatectomy
84. VALIDATION OF STEPHENSON NOMOGRAM TO PREDICT PSA PROGRESSION FOLLOWING SALVAGE RADIOTHERAPY AFTER RADICAL PROSTATECTOMY: RESULTS FROM THE SEARCH DATABASE
85. BODY MASS INDEX AND PROSTATE-SPECIFIC ANTIGEN AS A PREDICTOR OF ADVERSE PATHOLOGY AND BIOCHEMICAL RECURRENCE FOLLOWING RADICAL PROSTATECTOMY
86. Race and Time from Diagnosis to Radical Prostatectomy: Does Equal Access Mean Equal Timely Access to the Operating Room?—Results from the SEARCH Database
87. ASSOCIATION BETWEEN STATINS, OBESITY AND PROSTATE TUMOR INFLAMMATORY INFILTRATE IN MEN UNDERGOING RADICAL PROSTATECTOMY
88. STATIN MEDICATION USE AND THE RISK OF BIOCHEMICAL RECURRENCE FOLLOWING RADICAL PROSTATECTOMY: RESULTS FROM THE SEARCH DATABASE
89. DO H2 BLOCKERS LOWER SERUM PSA RESULTS? - DATA FROM THE SEARCH DATABASE
90. PREDICTORS OF CASTRATION RESISTANT PROSTATE CANCER IN MEN UNDERGOING SALVAGE ANDROGEN DEPRIVATION THERAPY - RESULTS FROM THE SEARCH DATABASE
91. INFLAMMATION IS ASSOCIATED WITH MORE AGGRESSIVE PROSTATE CANCER
92. IS PSA A POOR PREDICTOR OF PROSTATE CANCER IN OBESE MEN? - RESULTS FROM A EUROPEAN BIOPSY COHORT
93. Editorial Comment
94. Silencing of lactotransferrin expression by methylation in prostate cancer progression
95. 1418: Can Hemodilution Explain the Lower PSA Concentrations Among Obese Men?
96. 669: Effects and Mechanisms of Frequent Downregulation of Lactotransferrin (LTF) in Prostate Cancer
97. 435: Lactotransferrin: A Frequent Expression Down-Regulation in Prostate Cancer
98. Proteomics in prostate cancer
99. 2098 EMERGENT URETERAL STENT VERSUS NEPHROSTOMY FOR UROSEPTIC CALCULI: UTILIZATION AND OUTCOMES OVER 15 YEARS
100. 2237 DOES LONG-TERM ASPIRIN USE LOWER SERUM PSA LEVELS? - RESULTS FROM THE DUKE PROSTATE CENTER
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.